A need for standardized definitions for clinical studies of Pneumocystis.
Miller
Robert F
RF
Centre for Sexual Health and HIV Research, Department of Population Sciences and Primary Care, Royal Free and University College Medical School, University College London, London, United Kingdom. rmiller@gum.ucl.ac.uk
Huang
Laurence
L
D000935:Antifungal Agents / Q000494:pharmacology; D035843:Biomedical Research / Q000592:standards*; D004094:Dihydropteroate Synthase / Q000235:genetics; D025141:Drug Resistance, Fungal / Q000235:genetics*; D006801:Humans; D011010:Pneumocystis / Q000187:drug effects* / Q000201:enzymology* / Q000302:isolation & purification; D016720:Pneumocystis Infections / Q000175:diagnosis* / Q000188:drug therapy*; D013424:Sulfanilamides / Q000494:pharmacology
D000935:Antifungal Agents; D013424:Sulfanilamides; D004094:Dihydropteroate Synthase